Patents Assigned to Labrys Biologics, Inc.
  • COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS
    Publication number: 20170037117
    Abstract: The disclosure features compositions and methods for treating a metabolic disorder, including diabetes, conditions associated with inhibition of insulin secretion, or for increasing longevity. In some embodiments, the methods comprise administering an anti-CGRP antagonist antibody.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 9, 2017
    Applicants: Salk Institute for Biological Studies, The Regents of the University of California, Labrys Biologics, Inc.
    Inventors: Andrew Dillin, Celine Riera, Corey Goodman
  • Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
    Patent number: 9115194
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: August 25, 2015
    Assignee: Labrys Biologics, Inc.
    Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
  • METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
    Publication number: 20140314767
    Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.
    Type: Application
    Filed: October 18, 2013
    Publication date: October 23, 2014
    Applicant: Labrys Biologics, Inc.
    Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
  • METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
    Publication number: 20140308290
    Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.
    Type: Application
    Filed: June 4, 2014
    Publication date: October 16, 2014
    Applicant: Labrys Biologics, Inc.
    Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
  • Methods of treating vasomotor symptoms using antibodies
    Patent number: 8734802
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: May 27, 2014
    Assignee: Labrys Biologics, Inc.
    Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
  • Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
    Patent number: 8623366
    Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: January 7, 2014
    Assignee: Labrys Biologics, Inc.
    Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
  • Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
    Patent number: 8597649
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: December 3, 2013
    Assignee: Labrys Biologics, Inc.
    Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
  • Methods of using anti-CGRP antagonist antibodies
    Patent number: 8586045
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: November 19, 2013
    Assignee: Labrys Biologics, Inc.
    Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Lee Jones Collier, Arnon Rosenthal
  • ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME
    Publication number: 20130216535
    Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
    Type: Application
    Filed: April 25, 2013
    Publication date: August 22, 2013
    Applicant: Labrys Biologics, Inc.
    Inventor: Labrys Biologics, Inc.